Bal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve 1. Audited financial results of the Company for the quarter and financial year ended 31.03.2026.\r\n2. Audited standalone and consolidated accounts of the Company together with auditors report, for the F.Y ended 31.03.2026.\r\n3. To recommend dividend if any, for the F.Y 2025.26.\r\n4. To grant stock options to the employees of the Company under \Bal Pharma Ltd- Employee Stock Option Plan 2025\